These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31389139)

  • 21. Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.
    Egerton A; Howes OD; Houle S; McKenzie K; Valmaggia LR; Bagby MR; Tseng HH; Bloomfield MA; Kenk M; Bhattacharyya S; Suridjan I; Chaddock CA; Winton-Brown TT; Allen P; Rusjan P; Remington G; Meyer-Lindenberg A; McGuire PK; Mizrahi R
    Schizophr Bull; 2017 Mar; 43(2):293-301. PubMed ID: 28057720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased prefrontal cortical dopamine transmission in alcoholism.
    Narendran R; Mason NS; Paris J; Himes ML; Douaihy AB; Frankle WG
    Am J Psychiatry; 2014 Aug; 171(8):881-8. PubMed ID: 24874293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex.
    Lataster J; Collip D; Ceccarini J; Hernaus D; Haas D; Booij L; van Os J; Pruessner J; Van Laere K; Myin-Germeys I
    Schizophr Bull; 2014 Jan; 40(1):66-77. PubMed ID: 23363687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [
    Girgis RR; Slifstein M; Brucato G; Kegeles LS; Colibazzi T; Lieberman JA; Abi-Dargham A
    Mol Psychiatry; 2021 Jun; 26(6):2504-2513. PubMed ID: 33154566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.
    Urban NB; Slifstein M; Thompson JL; Xu X; Girgis RR; Raheja S; Haney M; Abi-Dargham A
    Biol Psychiatry; 2012 Apr; 71(8):677-83. PubMed ID: 22290115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Morgan CJ; Egerton A; Kapur S; Curran HV; Howes OD
    Biol Psychiatry; 2014 Mar; 75(6):470-8. PubMed ID: 23820822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis.
    Buchy L; Cannon TD; Anticevic A; Lyngberg K; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    BMC Psychiatry; 2015 Nov; 15():276. PubMed ID: 26553191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge.
    Hernaus D; Collip D; Lataster J; Ceccarini J; Kenis G; Booij L; Pruessner J; Van Laere K; van Winkel R; van Os J; Myin-Germeys I
    PLoS One; 2013; 8(6):e65662. PubMed ID: 23799032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficits in striatal dopamine release in cannabis dependence.
    van de Giessen E; Weinstein JJ; Cassidy CM; Haney M; Dong Z; Ghazzaoui R; Ojeil N; Kegeles LS; Xu X; Vadhan NP; Volkow ND; Slifstein M; Abi-Dargham A
    Mol Psychiatry; 2017 Jan; 22(1):68-75. PubMed ID: 27001613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts.
    Kennedy L; Ku BS; Addington J; Amir CM; Bearden CE; Cannon TD; Carrión R; Cornblatt B; Keshavan M; Perkins D; Mathalon D; Stone W; Walker E; Woods S; Cadenhead KS
    Schizophr Res; 2024 Sep; 271():319-331. PubMed ID: 39084107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.
    Smith CT; Dang LC; Cowan RL; Kessler RM; Zald DH
    Neuropharmacology; 2016 Sep; 108():394-402. PubMed ID: 27174408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Thermenos HW; Juelich RJ; DiChiara SR; Mesholam-Gately RI; Woodberry KA; Wojcik J; Makris N; Keshavan MS; Whitfield-Gabrieli S; Woo TU; Petryshen TL; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
    Schizophr Res; 2016 May; 173(1-2):1-12. PubMed ID: 26965745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
    Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR
    J Psychopharmacol; 2012 Jan; 26(1):144-9. PubMed ID: 21890594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.
    Tsukada H; Miyasato K; Nishiyama S; Fukumoto D; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Dec; 30(12):2144-53. PubMed ID: 15856080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global and Specific Cortical Volume Asymmetries in Individuals With Psychosis Risk Syndrome and Schizophrenia: A Mixed Cross-sectional and Longitudinal Perspective.
    Damme KSF; Vargas T; Calhoun V; Turner J; Mittal VA
    Schizophr Bull; 2020 Apr; 46(3):713-721. PubMed ID: 31682728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.
    van der Meer FJ; Velthorst E; Meijer CJ; Machielsen MW; de Haan L
    Curr Pharm Des; 2012; 18(32):5036-44. PubMed ID: 22716158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
    Frankle WG; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2022 Nov; 92(10):791-799. PubMed ID: 35791965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity.
    Zhao W; Zimmermann K; Zhou X; Zhou F; Fu M; Dernbach C; Scheele D; Weber B; Eckstein M; Hurlemann R; Kendrick KM; Becker B
    J Psychiatry Neurosci; 2020 Mar; 45(2):88-97. PubMed ID: 31509368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relation between stress-induced dopamine release in the ventromedial prefrontal cortex, fronto-striatal functional connectivity, and negative urgency: A multimodal investigation using [
    Leenaerts N; Ceccarini J; Sunaert S; Vrieze E
    Behav Brain Res; 2024 Aug; 471():115138. PubMed ID: 38969019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.